S&P 500

5.653,30

0,39%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

HSP

Hospira (HSP)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:HSP

<< Anterior 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
26/04/2011	13:20	Zacks	Hospira Beats, Backs Outlook - Analyst Blog	NYSE:HSP
26/04/2011	09:47	Dow Jones News	Hospira 1Q Profit Rises 5.8% On Prior-Year Charges	NYSE:HSP
26/04/2011	09:13	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:HSP
26/04/2011	08:58	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:HSP
26/04/2011	08:42	PR Newswire (US)	Hospira Reports First-Quarter 2011 Results	NYSE:HSP
25/04/2011	18:00	PR Newswire (US)	Hospira Board Authorizes $1 Billion Share Repurchase Program	NYSE:HSP
25/04/2011	06:45	Zacks	Earnings Preview: Hospira - Analyst Blog	NYSE:HSP
15/04/2011	19:09	Dow Jones News	UPDATE: Drug Makers Plan To Resume, Increase Leukemia Drug Shipments	NYSE:HSP
15/04/2011	16:48	Dow Jones News	Drug Makers Plan To Resume, Increase Leukemia Drug Shipments	NYSE:HSP
12/04/2011	08:00	Zacks	Hospira Pulled Down to Underperform - Analyst Blog	NYSE:HSP
11/04/2011	14:43	PR Newswire (US)	Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011	NYSE:HSP
07/04/2011	13:37	PR Newswire (US)	Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistanc	NYSE:HSP
04/04/2011	16:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:HSP
04/04/2011	15:45	PR Newswire (US)	Hospira to Host Conference Call for First-Quarter 2011 Results	NYSE:HSP
04/04/2011	12:05	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:HSP
04/04/2011	11:14	PR Newswire (US)	Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications	NYSE:HSP
01/04/2011	16:30	PR Newswire (US)	Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care	NYSE:HSP
30/03/2011	06:30	Zacks	Cephalon in Acquisition Mode - Analyst Blog	NYSE:HSP
28/03/2011	16:48	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:HSP
28/03/2011	16:42	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NYSE:HSP
24/03/2011	12:12	Dow Jones News	Hospira Sees More Generic Taxotere Sales In 1Q Than Forecast	NYSE:HSP
22/03/2011	18:10	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NYSE:HSP
16/03/2011	12:16	Dow Jones News	UPDATE: Covidien CEO To Retire, Succeeded By Head Of Devices	NYSE:HSP
14/03/2011	17:50	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NYSE:HSP
09/03/2011	16:01	Dow Jones News	CORRECT(3/8): Allergan CEO 2010 Compensation Valued At $12.6 Million	NYSE:HSP
09/03/2011	11:30	PR Newswire (US)	Hospira Announces U.S. Approval of Generic Docetaxel	NYSE:HSP
08/03/2011	20:45	Dow Jones News	Allergan CEO 2010 Total Compensation Valued At $12.6 Million	NYSE:HSP
07/03/2011	23:59	Dow Jones News	UPDATE: Hospira Names Allergan Veteran F. Michael Ball As CEO	NYSE:HSP
07/03/2011	22:46	Dow Jones News	Hospira Names Allergan Executive F. Michael Ball As New CEO	NYSE:HSP
07/03/2011	22:25	PR Newswire (US)	Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role	NYSE:HSP